SEOUL, South Korea, Feb. 26, 2026 /PRNewswire/ -- CJ BIO announced the publication of clinical research findings on its postbiotic ingredient, BiomeNrich™ POST SZ075, in an international peer-reviewed ...
Bio-Rad Laboratories, Inc. BIO is set to release second-quarter 2023 results on Aug 3 after the closing bell. The company posted adjusted earnings per share (EPS) of $3.34 in the last reported quarter ...
Only a small percentage of recently listed biotech and healthcare companies have posted share price gains in the past year, highlighting the risk of investing in the sector. Belite Bio, however, a ...
Oncocyte (NASDAQ:OCX) shares rallied 90% in post-market trading Thursday after the precision diagnostics developer announced a partnership with Bio-Rad (NYSE:BIO) for the global launch of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results